178 related articles for article (PubMed ID: 32681462)
21. Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group.
Popovic V; Damjanovic S; Micic D; Nesovic M; Djurovic M; Petakov M; Obradovic S; Zoric S; Simic M; Penezic Z; Marinkovic J
Clin Endocrinol (Oxf); 1998 Oct; 49(4):441-5. PubMed ID: 9876340
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of thyroid diseases in patients with acromegaly: experience of a Brazilian center.
Uchoa HB; Lima GA; Corrêa LL; Vidal AP; Cavallieri SA; Vaisman M; Buescu A; Gadelha MR
Arq Bras Endocrinol Metabol; 2013 Dec; 57(9):685-90. PubMed ID: 24402013
[TBL] [Abstract][Full Text] [Related]
23. Elastosonographic evaluation of thyroid nodules in acromegaly.
Scacchi M; Andrioli M; Carzaniga C; Vitale G; Moro M; Poggi L; Pecori Giraldi F; Fatti LM; Cavagnini F
Eur J Endocrinol; 2009 Oct; 161(4):607-13. PubMed ID: 19666699
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of differentiated thyroid carcinoma in acromegaly.
Tita P; Ambrosio MR; Scollo C; Carta A; Gangemi P; Bondanelli M; Vigneri R; degli Uberti EC; Pezzino V
Clin Endocrinol (Oxf); 2005 Aug; 63(2):161-7. PubMed ID: 16060909
[TBL] [Abstract][Full Text] [Related]
25. Association of changes in inflammation with variation in glycaemia, insulin resistance and secretion based on the KORA study.
de Las Heras Gala T; Herder C; Rutters F; Carstensen-Kirberg M; Huth C; Stehouwer CDA; Nijpels G; Schalkwijk C; Flyvbjerg A; Franks PW; Dekker J; Meisinger C; Koenig W; Roden M; Rathmann W; Peters A; Thorand B;
Diabetes Metab Res Rev; 2018 Nov; 34(8):e3063. PubMed ID: 30114727
[TBL] [Abstract][Full Text] [Related]
26. Increase of classic and nonclassic cardiovascular risk factors in patients with acromegaly.
Vilar L; Naves LA; Costa SS; Abdalla LF; Coelho CE; Casulari LA
Endocr Pract; 2007; 13(4):363-72. PubMed ID: 17669712
[TBL] [Abstract][Full Text] [Related]
27. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
[TBL] [Abstract][Full Text] [Related]
28. Obesity and risk of differentiated thyroid cancer: A large-scale case-control study.
He Q; Sun H; Li F; Liang N
Clin Endocrinol (Oxf); 2019 Dec; 91(6):869-878. PubMed ID: 31479527
[TBL] [Abstract][Full Text] [Related]
29. High incidence of thyroid cancer among patients with acromegaly.
Kaldrymidis D; Papadakis G; Tsakonas G; Kaldrymidis P; Flaskas T; Seretis A; Pantazi E; Kostoglou-Athanassiou I; Peppa M; Roussou P; Diamanti-Kandarakis E
J BUON; 2016; 21(4):989-993. PubMed ID: 27685924
[TBL] [Abstract][Full Text] [Related]
30. Identification of acromegalic patients at risk of developing colonic adenomas.
Bogazzi F; Cosci C; Sardella C; Costa A; Manetti L; Gasperi M; Rossi G; Bartalena L; Martino E
J Clin Endocrinol Metab; 2006 Apr; 91(4):1351-6. PubMed ID: 16449330
[TBL] [Abstract][Full Text] [Related]
31. Concentrations of leptin, adiponectin and other metabolic parameters in non-obese children with Down syndrome.
Tenneti N; Dayal D; Sharda S; Panigrahi I; Didi M; Attri SV; Sachdeva N; Bhalla AK
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):831-837. PubMed ID: 28749784
[TBL] [Abstract][Full Text] [Related]
32. Thyroid cancer is the most common cancer associated with acromegaly.
Gullu BE; Celik O; Gazioglu N; Kadioglu P
Pituitary; 2010 Sep; 13(3):242-8. PubMed ID: 20217483
[TBL] [Abstract][Full Text] [Related]
33. Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Awad S; Dorward N; Grieve J; Mendoza N; Muquit S; Grossman AB; Balkwill F; Korbonits M
Acta Neuropathol Commun; 2019 Nov; 7(1):172. PubMed ID: 31703742
[TBL] [Abstract][Full Text] [Related]
34. Elevated 1-hour post-load plasma glucose identifies obese youth with abnormal glucose metabolism and an unfavourable inflammatory profile.
Serbis A; Giapros V; Challa A; Chaliasos N; Siomou E
Clin Endocrinol (Oxf); 2018 Dec; 89(6):757-764. PubMed ID: 30229983
[TBL] [Abstract][Full Text] [Related]
35. Is there an association between acromegaly and thyroid carcinoma? A critical review of the literature.
Siegel G; Tomer Y
Endocr Res; 2005; 31(1):51-8. PubMed ID: 16238191
[TBL] [Abstract][Full Text] [Related]
36. Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients.
Kasayama S; Otsuki M; Takagi M; Saito H; Sumitani S; Kouhara H; Koga M; Saitoh Y; Ohnishi T; Arita N
Clin Endocrinol (Oxf); 2000 May; 52(5):549-55. PubMed ID: 10792333
[TBL] [Abstract][Full Text] [Related]
37. Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors.
Whyte E; Nezu M; Chik C; Tateno T
Endocrinol Metab (Seoul); 2023 Dec; 38(6):631-654. PubMed ID: 37964483
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory potential of the diet and association with risk of differentiated thyroid cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
Lécuyer L; Laouali N; Dossus L; Shivappa N; Hébert JR; Agudo A; Tjonneland A; Halkjaer J; Overvad K; Katzke VA; Le Cornet C; Schulze MB; Jannasch F; Palli D; Agnoli C; Tumino R; Dragna L; Iannuzzo G; Jensen TE; Brustad M; Skeie G; Zamora-Ros R; Rodriguez-Barranco M; Amiano P; Chirlaque MD; Ardanaz E; Almquist M; Sonestedt E; Sandström M; Nilsson LM; Weiderpass E; Huybrechts I; Rinaldi S; Boutron-Ruault MC; Truong T
Eur J Nutr; 2022 Oct; 61(7):3625-3635. PubMed ID: 35635567
[TBL] [Abstract][Full Text] [Related]
39. Serum leptin levels and GHR-d3/fl gene polymorphism in acromegalic patients with thyroid nodules.
Topsakal S; Akin F; Turgut S; Yerlikaya E; Yaylali GF
Adv Clin Exp Med; 2017; 26(2):281-286. PubMed ID: 28791847
[TBL] [Abstract][Full Text] [Related]
40. An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors.
Alshaikh OM; Asa SL; Mete O; Ezzat S
Endocr Pathol; 2019 Jun; 30(2):118-127. PubMed ID: 30706322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
